hpo_id1,hpo_term1,hpo_id2,hpo_term2,similarity_score,inverse_verified_by_llm
HP:0000040,Long penis,HP:0000054,Micropenis,0.7602,t
HP:0000044,Hypogonadotropic hypogonadism,HP:0000815,Hypergonadotropic hypogonadism,0.9926,t
HP:0000053,Macroorchidism,HP:0008734,Decreased testicular size,0.8146,t
HP:0000059,Hypoplastic labia majora,HP:0012882,Hyperplastic labia majora,0.9837,t
HP:0000105,Enlarged kidney,HP:0000089,Renal hypoplasia,0.8357,t
HP:0000117,Renal phosphate wasting,HP:0005571,Increased renal tubular phosphate reabsorption,0.8932,t
HP:0000154,Wide mouth,HP:0000160,Narrow mouth,0.9497,t
HP:0000158,Macroglossia,HP:0000171,Microglossia,0.9375,t
HP:0000158,Macroglossia,HP:0012473,Tongue atrophy,0.9047,t
HP:0000176,Submucous cleft hard palate,HP:0011819,Submucous cleft soft palate,0.9933,f
HP:0000179,Thick lower lip vermilion,HP:0010282,Thin lower lip vermilion,0.9902,t
HP:0000185,Cleft soft palate,HP:0410005,Cleft hard palate,0.9844,f
HP:0000188,Short upper lip,HP:0011341,Long upper lip,0.9862,t
HP:0000215,Thick upper lip vermilion,HP:0000219,Thin upper lip vermilion,0.9915,t
HP:0000233,Thin vermilion border,HP:0012471,Thick vermilion border,0.9919,t
HP:0000239,Large fontanelles,HP:0005486,Small fontanelle,0.9768,t
HP:0000248,Brachycephaly,HP:0000268,Dolichocephaly,0.8848,t
HP:0000252,Microcephaly,HP:0040194,Increased head circumference,0.8090,t
HP:0000252,Microcephaly,HP:0000256,Macrocephaly,0.9598,t
HP:0000253,Progressive microcephaly,HP:0004481,Progressive macrocephaly,0.9753,t
HP:0000255,Acute sinusitis,HP:0011109,Chronic sinusitis,0.9406,t
HP:0000260,Wide anterior fontanel,HP:0000237,Small anterior fontanelle,0.9397,t
HP:0000272,Malar flattening,HP:0010620,Malar prominence,0.9092,t
HP:0000274,Small face,HP:0100729,Large face,0.9725,t
HP:0000275,Narrow face,HP:0000283,Broad face,0.9378,t
HP:0000276,Long face,HP:0011219,Short face,0.9748,t
HP:0000287,Increased facial adipose tissue,HP:0009019,Progressive loss of facial adipose tissue,0.9375,t
HP:0000289,Broad philtrum,HP:0011829,Narrow philtrum,0.9386,t
HP:0000292,Loss of facial adipose tissue,HP:0000287,Increased facial adipose tissue,0.9453,t
HP:0000294,Low anterior hairline,HP:0009890,High anterior hairline,0.9914,t
HP:0000303,Mandibular prognathia,HP:0000347,Micrognathia,0.8974,t
HP:0000316,Hypertelorism,HP:0000601,Hypotelorism,0.8740,t
HP:0000319,Smooth philtrum,HP:0002002,Deep philtrum,0.9327,t
HP:0000322,Short philtrum,HP:0000343,Long philtrum,0.9818,t
HP:0000327,Hypoplasia of the maxilla,HP:0430028,Hyperplasia of the maxilla,0.9809,t
HP:0000331,Short chin,HP:0400000,Tall chin,0.9239,t
HP:0000336,Prominent supraorbital ridges,HP:0009891,Underdeveloped supraorbital ridges,0.9283,t
HP:0000337,Broad forehead,HP:0000341,Narrow forehead,0.8724,t
HP:0000350,Small forehead,HP:0002003,Large forehead,0.9623,t
HP:0000371,Acute otitis media,HP:0000389,Chronic otitis media,0.9569,t
HP:0000400,Macrotia,HP:0008551,Microtia,0.8330,t
HP:0000418,Narrow nasal ridge,HP:0012811,Wide nasal ridge,0.9762,t
HP:0000426,Prominent nasal bridge,HP:0005280,Depressed nasal bridge,0.9510,t
HP:0000431,Wide nasal bridge,HP:0000446,Narrow nasal bridge,0.9597,t
HP:0000444,Convex nasal ridge,HP:0011120,Concave nasal ridge,0.8903,t
HP:0000445,Wide nose,HP:0000460,Narrow nose,0.9059,t
HP:0000455,Broad nasal tip,HP:0011832,Narrow nasal tip,0.9261,t
HP:0000470,Short neck,HP:0000472,Long neck,0.9556,t
HP:0000482,Microcornea,HP:0000485,Megalocornea,0.9239,t
HP:0000494,Downslanted palpebral fissures,HP:0000582,Upslanted palpebral fissure,0.9554,t
HP:0000527,Long eyelashes,HP:0010764,Short eyelashes,0.9886,t
HP:0000571,Hypometric saccades,HP:0007338,Hypermetric saccades,0.9757,t
HP:0000574,Thick eyebrow,HP:0045074,Thin eyebrow,0.9300,t
HP:0000581,Blepharophimosis,HP:0000637,Long palpebral fissure,0.8228,t
HP:0000594,Shallow anterior chamber,HP:0007765,Deep anterior chamber,0.9245,t
HP:0000599,Abnormality of the frontal hairline,HP:0030141,Abnormality of the posterior hairline,0.9848,f
HP:0000633,Decreased lacrimation,HP:0009926,Epiphora,0.8287,t
HP:0000637,Long palpebral fissure,HP:0045025,Narrow palpebral fissure,0.9871,t
HP:0000637,Long palpebral fissure,HP:0012745,Short palpebral fissure,0.9963,t
HP:0000653,Sparse eyelashes,HP:0011231,Prominent eyelashes,0.9681,t
HP:0000668,Hypodontia,HP:0011069,Supernumerary tooth,0.8391,t
HP:0000684,Delayed eruption of teeth,HP:0006288,Advanced eruption of teeth,0.9732,t
HP:0000691,Microdontia,HP:0001572,Macrodontia,0.8932,t
HP:0000778,Hypoplasia of the thymus,HP:0010516,Thymus hyperplasia,0.9254,t
HP:0000821,Hypothyroidism,HP:0000836,Hyperthyroidism,0.9712,t
HP:0000822,Hypertension,HP:0002615,Hypotension,0.8328,t
HP:0000829,Hypoparathyroidism,HP:0000843,Hyperparathyroidism,0.9553,t
HP:0000835,Adrenal hypoplasia,HP:0008221,Adrenal hyperplasia,0.9781,t
HP:0000842,Hyperinsulinemia,HP:0040216,Hypoinsulinemia,0.9594,t
HP:0000860,Parathyroid hypoplasia,HP:0008208,Parathyroid hyperplasia,0.9844,t
HP:0000870,Increased circulating prolactin concentration,HP:0008202,Reduced circulating prolactin concentration,0.9935,t
HP:0000890,Long clavicles,HP:0000894,Short clavicles,0.9905,t
HP:0000953,Hyperpigmentation of the skin,HP:0001010,Hypopigmentation of the skin,0.9644,t
HP:0000963,Thin skin,HP:0001072,Thickened skin,0.8992,t
HP:0000966,Hypohidrosis,HP:0000975,Hyperhidrosis,0.9532,t
HP:0000973,Cutis laxa,HP:0000974,Hyperextensible skin,0.8098,t
HP:0000998,Hypertrichosis,HP:0008070,Sparse hair,0.7698,t
HP:0001034,Hypermelanotic macule,HP:0009719,Hypomelanotic macule,0.9840,t
HP:0001169,Broad palm,HP:0004283,Narrow palm,0.8887,t
HP:0001176,Large hands,HP:0200055,Small hand,0.8951,t
HP:0001196,Short umbilical cord,HP:0011417,Long umbilical cord,0.9906,t
HP:0001238,Slender finger,HP:0001500,Broad finger,0.7850,t
HP:0001252,Hypotonia,HP:0001276,Hypertonia,0.8859,t
HP:0001265,Hyporeflexia,HP:0001347,Hyperreflexia,0.9636,t
HP:0001315,Reduced tendon reflexes,HP:0001347,Hyperreflexia,0.8325,t
HP:0001376,Limitation of joint mobility,HP:0001382,Joint hypermobility,0.7998,t
HP:0001403,Macrovesicular hepatic steatosis,HP:0001414,Microvesicular hepatic steatosis,0.9769,t
HP:0001413,Micronodular cirrhosis,HP:0006577,Macronodular cirrhosis,0.9773,t
HP:0001476,Delayed closure of the anterior fontanelle,HP:0005458,Premature closure of fontanelles,0.9670,t
HP:0001477,Compensatory chin elevation,HP:0031706,Compensatory chin depression,0.9466,t
HP:0001520,Large for gestational age,HP:0001518,Small for gestational age,0.9908,t
HP:0001558,Decreased fetal movement,HP:0010519,Increased fetal movement,0.9874,t
HP:0001561,Polyhydramnios,HP:0001562,Oligohydramnios,0.9777,t
HP:0001611,Hypernasal speech,HP:0100271,Hyponasal speech,0.9519,t
HP:0001620,Abnormally high-pitched voice,HP:0010300,Abnormally low-pitched voice,0.9947,t
HP:0001640,Cardiomegaly,HP:0001961,Hypoplastic heart,0.8765,t
HP:0001649,Tachycardia,HP:0001662,Bradycardia,0.9777,t
HP:0001657,Prolonged QT interval,HP:0012232,Shortened QT interval,0.9625,t
HP:0001674,Complete atrioventricular canal defect,HP:0011577,Partial atrioventricular canal defect,0.9916,f
HP:0001688,Sinus bradycardia,HP:0011703,Sinus tachycardia,0.9808,t
HP:0001722,High-output congestive heart failure,HP:0009805,Low-output congestive heart failure,0.9970,t
HP:0001735,Acute pancreatitis,HP:0006280,Chronic pancreatitis,0.9705,t
HP:0001757,High-frequency sensorineural hearing impairment,HP:0008573,Low-frequency sensorineural hearing impairment,0.9980,f
HP:0001769,Broad foot,HP:0001786,Narrow foot,0.9295,t
HP:0001773,Short foot,HP:0001833,Long foot,0.9389,t
HP:0001805,Onychogryphosis,HP:0001816,Thin nail,0.7459,f
HP:0001821,Broad nail,HP:0011313,Narrow nail,0.8758,t
HP:0001831,Short toe,HP:0010511,Long toe,0.9633,t
HP:0001837,Broad toe,HP:0011308,Slender toe,0.7808,t
HP:0001847,Long hallux,HP:0010109,Short hallux,0.9654,t
HP:0001882,Leukopenia,HP:0001974,Leukocytosis,0.9416,t
HP:0001899,Increased hematocrit,HP:0031851,Reduced hematocrit,0.9810,t
HP:0001919,Acute kidney injury,HP:0003774,Stage 5 chronic kidney disease,0.8436,t
HP:0001935,Microcytic anemia,HP:0001972,Macrocytic anemia,0.9742,t
HP:0001943,Hypoglycemia,HP:0003074,Hyperglycemia,0.9668,t
HP:0001945,Fever,HP:0002045,Hypothermia,0.7518,t
HP:0001987,Hyperammonemia,HP:0100493,Hypoammonemia,0.9655,t
HP:0002057,Prominent glabella,HP:0011222,Depressed glabella,0.9454,t
HP:0002148,Hypophosphatemia,HP:0002905,Hyperphosphatemia,0.9674,t
HP:0002149,Hyperuricemia,HP:0003537,Hypouricemia,0.9654,t
HP:0002150,Hypercalciuria,HP:0003127,Hypocalciuria,0.9605,t
HP:0002152,Hyperproteinemia,HP:0003075,Hypoproteinemia,0.9743,t
HP:0002153,Hyperkalemia,HP:0002900,Hypokalemia,0.9529,t
HP:0002154,Hyperglycinemia,HP:0012277,Hypoglycinemia,0.9671,t
HP:0002155,Hypertriglyceridemia,HP:0012153,Hypotriglyceridemia,0.9715,t
HP:0002161,Hyperlysinemia,HP:0500142,Hypolysinemia,0.9245,t
HP:0002162,Low posterior hairline,HP:0012891,High posterior hairline,0.9913,t
HP:0002213,Fine hair,HP:0100874,Thick hair,0.9341,t
HP:0002250,Abnormal large intestine morphology,HP:0002244,Abnormal small intestine morphology,0.9952,f
HP:0002375,Hypokinesia,HP:0002487,Hyperkinetic movements,0.9438,t
HP:0002395,Lower limb hyperreflexia,HP:0002600,Hyporeflexia of lower limbs,0.9339,t
HP:0002488,Acute leukemia,HP:0005558,Chronic leukemia,0.9570,t
HP:0002490,Increased CSF lactate,HP:0030086,Reduced CSF lactate,0.9934,t
HP:0002509,Limb hypertonia,HP:0012389,Appendicular hypotonia,0.9117,t
HP:0002516,Increased intracranial pressure,HP:0012641,Decreased intracranial pressure,0.9833,t
HP:0002562,Low-set nipples,HP:6000229,High-set nipples,0.9860,t
HP:0002594,Pancreatic hypoplasia,HP:0006277,Pancreatic hyperplasia,0.9775,t
HP:0002677,Small foramen magnum,HP:0002700,Large foramen magnum,0.9948,t
HP:0002684,Thickened calvaria,HP:0010539,Thin calvarium,0.9487,t
HP:0002690,Large sella turcica,HP:0010538,Small sella turcica,0.9951,t
HP:0002714,Downturned corners of mouth,HP:0010805,Upturned corners of mouth,0.9954,t
HP:0002716,Lymphadenopathy,HP:0002732,Lymph node hypoplasia,0.9253,t
HP:0002720,Decreased circulating IgA concentration,HP:0003261,Increased circulating IgA concentration,0.9920,t
HP:0002731,Decreased lymphocyte apoptosis,HP:0030887,Increased lymphocyte apoptosis,0.9947,t
HP:0002789,Tachypnea,HP:0046507,Bradypnea,0.9623,t
HP:0002791,Hypoventilation,HP:0002883,Hyperventilation,0.9311,t
HP:0002850,Decreased circulating total IgM,HP:0003496,Increased circulating IgM level,0.9212,t
HP:0002901,Hypocalcemia,HP:0003072,Hypercalcemia,0.9554,t
HP:0002902,Hyponatremia,HP:0003228,Hypernatremia,0.9743,t
HP:0002904,Hyperbilirubinemia,HP:0033480,Hypobilirubinemia,0.9753,t
HP:0002907,Microscopic hematuria,HP:0012587,Macroscopic hematuria,0.9589,t
HP:0002914,Hyperchloriduria,HP:0012601,Hypochloriduria,0.9725,t
HP:0002917,Hypomagnesemia,HP:0002918,Hypermagnesemia,0.9728,t
HP:0002922,Increased CSF protein concentration,HP:0025457,Decreased CSF protein concentration,0.9948,t
HP:0002938,Lumbar hyperlordosis,HP:0034770,Lumbar hypolordosis,0.9753,t
HP:0003022,Hypoplasia of the ulna,HP:0003988,Long ulna,0.8387,t
HP:0003038,Fibular hypoplasia,HP:0003085,Long fibula,0.8265,t
HP:0003073,Hypoalbuminemia,HP:0012117,Hyperalbuminemia,0.9722,t
HP:0003077,Hyperlipidemia,HP:0045014,Hypolipidemia,0.9173,t
HP:0003109,Hyperphosphaturia,HP:0012365,Hypophosphaturia,0.9679,t
HP:0003113,Hypochloremia,HP:0011423,Hyperchloremia,0.9452,t
HP:0003124,Hypercholesterolemia,HP:0003146,Hypocholesterolemia,0.9814,t
HP:0003125,Reduced factor VIII activity,HP:0030977,Increased factor VIII activity,0.9813,t
HP:0003138,Increased blood urea nitrogen,HP:0031969,Reduced blood urea nitrogen,0.9896,t
HP:0003141,Increased LDL cholesterol concentration,HP:0003563,Decreased LDL cholesterol concentration,0.9967,t
HP:0003141,Increased LDL cholesterol concentration,HP:0012184,Increased HDL cholesterol concentration,0.9871,t
HP:0003189,Long nose,HP:0003196,Short nose,0.9642,t
HP:0003194,Short nasal bridge,HP:0033142,Long nasal bridge,0.9864,t
HP:0003202,Skeletal muscle atrophy,HP:0003712,Skeletal muscle hypertrophy,0.9465,t
HP:0003217,Hyperglutaminemia,HP:0500147,Hypoglutaminemia,0.9762,t
HP:0003231,Hypertyrosinemia,HP:0500133,Hypotyrosinemia,0.9449,t
HP:0003233,Decreased HDL cholesterol concentration,HP:0003563,Decreased LDL cholesterol concentration,0.9870,f
HP:0003233,Decreased HDL cholesterol concentration,HP:0012184,Increased HDL cholesterol concentration,0.9958,t
HP:0003235,Hypermethioninemia,HP:0003658,Hypomethioninemia,0.9792,t
HP:0003259,Elevated circulating creatinine concentration,HP:0012101,Decreased serum creatinine,0.9564,t
HP:0003281,Increased circulating ferritin concentration,HP:0012343,Decreased circulating ferritin concentration,0.9956,t
HP:0003282,Decreased circulating alkaline phosphatase activity,HP:0003155,Elevated circulating alkaline phosphatase concentration,0.9837,t
HP:0003292,Decreased serum leptin,HP:0031793,Increased serum leptin,0.9917,t
HP:0003348,Hyperalaninemia,HP:0500154,Hypoalaninemia,0.9609,t
HP:0003351,Decreased circulating renin concentration,HP:0000848,Increased circulating renin concentration,0.9928,t
HP:0003354,Hyperthreoninemia,HP:0500136,Hypothreoninemia,0.9272,t
HP:0003359,Decreased urinary sulfate,HP:0012613,Increased urinary sulfate,0.9943,t
HP:0003371,Enlargement of the proximal femoral epiphysis,HP:0003090,Hypoplasia of the capital femoral epiphysis,0.9645,t
HP:0003387,Decreased number of large peripheral myelinated nerve fibers,HP:0007249,Decreased number of small peripheral myelinated nerve fibers,0.9948,f
HP:0003429,CNS hypomyelination,HP:0012754,CNS hypermyelination,0.9782,t
HP:0003551,Difficulty climbing stairs,HP:0033235,Difficulty descending stairs,0.9677,f
HP:0003565,Elevated erythrocyte sedimentation rate,HP:0025022,Decreased erythrocyte sedimentation rate,0.9801,t
HP:0003676,Progressive,HP:0003680,Nonprogressive,0.6610,t
HP:0003700,Generalized amyotrophy,HP:0003720,Generalized muscle hypertrophy,0.9232,t
HP:0003745,Sporadic,HP:0031796,Recurrent,0.7539,t
HP:0003785,Decreased CSF homovanillic acid concentration,HP:0034201,Increased CSF homovanillic acid concentration,0.9976,t
HP:0003829,Typified by incomplete penetrance,HP:0034950,Typified by complete penetrance,0.9844,t
HP:0003898,Large humeral epiphyses,HP:0003900,Small humeral epiphyses,0.9951,t
HP:0004005,Large radial epiphyses,HP:0004010,Small radial epiphyses,0.9932,t
HP:0004237,Large carpal bones,HP:0001498,Carpal bone hypoplasia,0.8924,t
HP:0004279,Short palm,HP:0011302,Long palm,0.9540,t
HP:0004313,Decreased circulating antibody concentration,HP:0010702,Increased circulating antibody concentration,0.9918,t
HP:0004315,Decreased circulating IgG concentration,HP:0003237,Increased circulating IgG concentration,0.9918,t
HP:0004319,Decreased circulating aldosterone concentration,HP:0000859,Increased circulating aldosterone concentration,0.9951,t
HP:0004322,Short stature,HP:0000098,Tall stature,0.9296,t
HP:0004325,Decreased body weight,HP:0004324,Increased body weight,0.9770,t
HP:0004330,Increased skull ossification,HP:0004331,Decreased skull ossification,0.9948,t
HP:0004349,Reduced bone mineral density,HP:0011001,Increased bone mineral density,0.9776,t
HP:0004369,Decreased circulating purine concentration,HP:0004368,Increased circulating purine concentration,0.9923,t
HP:0004469,Chronic bronchitis,HP:0012388,Acute bronchitis,0.9549,t
HP:0004488,Macrocephaly at birth,HP:0011451,Primary microcephaly,0.9233,t
HP:0004528,Generalized hypotrichosis,HP:0004554,Generalized hypertrichosis,0.9010,t
HP:0004660,Hypoplasia of facial musculature,HP:0012892,Facial muscle hypertrophy,0.8964,t
HP:0004729,Acute tubulointerstitial nephritis,HP:0004743,Chronic tubulointerstitial nephritis,0.9925,t
HP:0004808,Acute myeloid leukemia,HP:0005506,Chronic myelogenous leukemia,0.9785,f
HP:0004820,Acute myelomonocytic leukemia,HP:0012325,Chronic myelomonocytic leukemia,0.9922,f
HP:0004821,Hypersegmentation of neutrophil nuclei,HP:0011447,Hyposegmentation of neutrophil nuclei,0.9841,t
HP:0004826,Folate-unresponsive megaloblastic anemia,HP:0004851,Folate-responsive megaloblastic anemia,0.9842,t
HP:0004879,Intermittent hyperventilation,HP:0004881,Episodic hypoventilation,0.9083,t
HP:0004905,Reduced circulating vitamin A concentration,HP:4000212,Increased circulating vitamin A concentration,0.9884,t
HP:0004923,Hyperphenylalaninemia,HP:0500141,Hypophenylalaninemia,0.9416,t
HP:0004966,Medial calcification of large arteries,HP:0012458,Medial calcification of small arteries,0.9959,f
HP:0005165,Shortened PR interval,HP:0012248,Prolonged PR interval,0.9616,t
HP:0005170,Complete heart block with broad QRS complexes,HP:0005178,Complete heart block with narrow QRS complexes,0.9531,t
HP:0005272,Prominent nasolabial fold,HP:0010801,Underdeveloped nasolabial fold,0.9288,t
HP:0005274,Prominent nasal tip,HP:0005278,Hypoplastic nasal tip,0.8754,t
HP:0005310,Large vessel vasculitis,HP:0011944,Small vessel vasculitis,0.9959,t
HP:0005323,Hemifacial hypertrophy,HP:0011331,Hemifacial atrophy,0.9600,t
HP:0005445,Enlarged posterior fossa,HP:0040010,Small posterior fossa,0.9496,t
HP:0005479,Decreased circulating IgE concentration,HP:0003212,Increased circulating IgE concentration,0.9934,t
HP:0005484,Secondary microcephaly,HP:0005490,Postnatal macrocephaly,0.9279,t
HP:0005520,Chronic disseminated intravascular coagulation,HP:0011880,Acute disseminated intravascular coagulation,0.9807,f
HP:0005528,Bone marrow hypocellularity,HP:0031020,Bone marrow hypercellularity,0.9841,t
HP:0005537,Decreased mean platelet volume,HP:0011877,Increased mean platelet volume,0.9935,t
HP:0005550,Chronic lymphatic leukemia,HP:0006721,Acute lymphoblastic leukemia,0.9630,f
HP:0005585,Spotty hyperpigmentation,HP:0005590,Spotty hypopigmentation,0.9554,t
HP:0005819,Short middle phalanx of finger,HP:0012298,Long middle phalanx of finger,0.9964,t
HP:0005961,Hypoargininemia,HP:0500153,Hyperargininemia,0.9770,t
HP:0005990,Thyroid hypoplasia,HP:0008249,Thyroid hyperplasia,0.9783,t
HP:0006127,Long proximal phalanx of finger,HP:0010241,Short proximal phalanx of finger,0.9966,t
HP:0006155,Long phalanx of finger,HP:0009803,Short phalanx of finger,0.9948,t
HP:0006184,Decreased palmar creases,HP:0006191,Deep palmar crease,0.9452,t
HP:0006267,Large placenta,HP:0006266,Small placenta,0.9865,t
HP:0006329,Alveolar process hypoplasia,HP:0009085,Alveolar ridge overgrowth,0.9267,t
HP:0006336,Short dental root,HP:0033189,Radiculomegaly,0.7449,f
HP:0006429,Broad femoral neck,HP:0008819,Narrow femoral neck,0.9696,t
HP:0006554,Acute hepatic failure,HP:0100626,Chronic hepatic failure,0.9545,t
HP:0007048,Large basal ganglia,HP:0012697,Small basal ganglia,0.9869,t
HP:0007074,Thick corpus callosum,HP:0033725,Thin corpus callosum,0.9896,t
HP:0007103,Hypointensity of cerebral white matter on MRI,HP:0030890,Hyperintensity of cerebral white matter on MRI,0.9798,t
HP:0007149,Distal upper limb amyotrophy,HP:0040267,Distal upper limb muscle hypertrophy,0.9526,t
HP:0007182,Peripheral hypomyelination,HP:0030173,Peripheral hypermyelination,0.9732,t
HP:0007183,Focal T2 hyperintense basal ganglia lesion,HP:0012752,Focal T2 hypointense basal ganglia lesion,0.9903,t
HP:0007410,Palmoplantar hyperhidrosis,HP:0034012,Palmoplantar hypohidrosis,0.9885,t
HP:0007440,Generalized hyperpigmentation,HP:0007513,Generalized hypopigmentation,0.9405,t
HP:0007535,Hypopigmented streaks,HP:0007572,Hyperpigmented streaks,0.9121,t
HP:0007803,Monochromacy,HP:0007939,Blue cone monochromacy,0.9361,f
HP:0007840,Long upper eyelashes,HP:0040054,Short upper eyelashes,0.9921,t
HP:0007894,Hypopigmentation of the fundus,HP:0011512,Hyperpigmentation of the fundus,0.9628,t
HP:0007975,Hypometric horizontal saccades,HP:0032013,Hypermetric horizontal saccades,0.9740,t
HP:0007988,Macular hypopigmentation,HP:0011509,Macular hyperpigmentation,0.9401,t
HP:0008001,Foveal hyperpigmentation,HP:0012643,Foveal hypopigmentation,0.9522,t
HP:0008163,Decreased circulating cortisol level,HP:0003118,Increased circulating cortisol level,0.9940,t
HP:0008165,Decreased helper T cell proportion,HP:0500264,Increased helper T cell proportion,0.9933,t
HP:0008179,Decreased Arden ratio of electrooculogram,HP:0031155,Increased Arden ratio of electrooculogram,0.9971,t
HP:0008182,Adrenocortical hypoplasia,HP:6000152,Adrenocortical hyperplasia,0.9799,t
HP:0008214,Decreased serum estradiol,HP:0025134,Increased serum estradiol,0.9940,t
HP:0008233,Decreased circulating progesterone,HP:0031216,Increased circulating progesterone,0.9895,t
HP:0008244,Congenital adrenal hypoplasia,HP:0008258,Congenital adrenal hyperplasia,0.9899,t
HP:0008348,Decreased circulating IgG2 concentration,HP:0032299,Increased circulating IgG2 level,0.9826,t
HP:0008358,Hyperprolinemia,HP:0500139,Hypoprolinemia,0.9690,t
HP:0008593,Prominent antitragus,HP:0011251,Underdeveloped antitragus,0.8749,t
HP:0008665,Clitoral hypertrophy,HP:0000060,Clitoral hypoplasia,0.9317,t
HP:0008818,Large iliac wing,HP:0002866,Hypoplastic iliac wing,0.8869,t
HP:0008948,Proximal upper limb amyotrophy,HP:0040266,Proximal upper limb muscle hypertrophy,0.9510,t
HP:0008972,Decreased activity of mitochondrial respiratory chain,HP:0040015,Increased activity of mitochondrial respiratory chain,0.9942,t
HP:0009060,Scapular muscle atrophy,HP:0012895,Scapular muscle hypertrophy,0.9559,t
HP:0009147,Enlarged epiphysis of the distal phalanx of the 5th finger,HP:0009148,Small epiphysis of the distal phalanx of the 5th finger,0.9950,t
HP:0009158,Enlarged epiphysis of the proximal phalanx of the 5th finger,HP:0009159,Small epiphysis of the proximal phalanx of the 5th finger,0.9950,t
HP:0009206,Enlarged epiphysis of the middle phalanx of the 5th finger,HP:0009211,Small epiphysis of the middle phalanx of the 5th finger,0.9944,t
HP:0009217,Enlarged epiphysis of the middle phalanx of the 4th finger,HP:0009222,Small epiphysis of the middle phalanx of the 4th finger,0.9942,t
HP:0009253,Enlarged epiphysis of the distal phalanx of the 4th finger,HP:0009258,Small epiphysis of the distal phalanx of the 4th finger,0.9949,t
HP:0009264,Enlarged epiphysis of the proximal phalanx of the 4th finger,HP:0009269,Small epiphysis of the proximal phalanx of the 4th finger,0.9949,t
HP:0009324,Enlarged epiphysis of the middle phalanx of the 3rd finger,HP:0009329,Small epiphysis of the middle phalanx of the 3rd finger,0.9941,t
HP:0009338,Enlarged epiphysis of the distal phalanx of the 3rd finger,HP:0009343,Small epiphysis of the distal phalanx of the 3rd finger,0.9948,t
HP:0009349,Enlarged epiphysis of the proximal phalanx of the 3rd finger,HP:0009354,Small epiphysis of the proximal phalanx of the 3rd finger,0.9948,t
HP:0009385,Enlarged epiphyses of the 5th finger,HP:0009390,Small epiphyses of the 5th finger,0.9889,t
HP:0009396,Enlarged epiphyses of the 4th finger,HP:0009401,Small epiphyses of the 4th finger,0.9885,t
HP:0009413,Enlarged epiphyses of the 3rd finger,HP:0009418,Small epiphyses of the 3rd finger,0.9880,t
HP:0009491,Enlarged epiphyses of the 2nd finger,HP:0009496,Small epiphyses of the 2nd finger,0.9887,t
HP:0009505,Enlarged epiphysis of the distal phalanx of the 2nd finger,HP:0009510,Small epiphysis of the distal phalanx of the 2nd finger,0.9951,t
HP:0009516,Enlarged epiphysis of the middle phalanx of the 2nd finger,HP:0009521,Small epiphysis of the middle phalanx of the 2nd finger,0.9944,t
HP:0009527,Enlarged epiphysis of the proximal phalanx of the 2nd finger,HP:0009532,Small epiphysis of the proximal phalanx of the 2nd finger,0.9950,t
HP:0009667,Enlarged epiphysis of the proximal phalanx of the thumb,HP:0009672,Small epiphysis of the proximal phalanx of the thumb,0.9951,t
HP:0009678,Enlarged epiphysis of the distal phalanx of the thumb,HP:0009683,Small epiphysis of the distal phalanx of the thumb,0.9951,t
HP:0009689,Enlarged thumb epiphysis,HP:0009694,Small thumb epiphysis,0.9848,t
HP:0009746,Thick nasal septum,HP:0009936,Narrow nasal septum,0.8816,t
HP:0009748,Large earlobe,HP:0000385,Small earlobe,0.9887,t
HP:0009778,Short thumb,HP:0032524,Long thumb,0.9601,t
HP:0009804,Tooth agenesis,HP:0011069,Supernumerary tooth,0.8636,t
HP:0009882,Short distal phalanx of finger,HP:0012299,Long distal phalanx of finger,0.9964,t
HP:0009924,Aplasia/Hypoplasia involving the nose,HP:0000448,Prominent nose,0.7517,t
HP:0009931,Enlarged naris,HP:0009933,Narrow naris,0.9184,t
HP:0010018,Enlarged epiphysis of the 1st metacarpal,HP:0010023,Small epiphysis of the 1st metacarpal,0.9927,t
HP:0010049,Short metacarpal,HP:0010493,Long metacarpals,0.9513,t
HP:0010116,Enlarged epiphyses of the hallux,HP:0010121,Small epiphyses of the hallux,0.9896,t
HP:0010130,Enlarged epiphysis of the proximal phalanx of the hallux,HP:0010135,Small epiphysis of the proximal phalanx of the hallux,0.9954,t
HP:0010141,Enlarged epiphysis of the distal phalanx of the hallux,HP:0010146,Small epiphysis of the distal phalanx of the hallux,0.9953,t
HP:0010152,Enlarged epiphysis of the 1st metatarsal,HP:0010157,Small epiphysis of the 1st metatarsal,0.9923,t
HP:0010165,Enlarged epiphyses of the toes,HP:0010170,Small epiphyses of the toes,0.9848,t
HP:0010231,Enlarged epiphyses of the phalanges of the hand,HP:0010236,Small epiphyses of the phalanges of the hand,0.9923,t
HP:0010249,Enlarged epiphyses of the distal phalanges of the hand,HP:0010254,Small epiphyses of the distal phalanges of the hand,0.9948,t
HP:0010260,Enlarged epiphyses of the middle phalanges of the hand,HP:0010265,Small epiphyses of the middle phalanges of the hand,0.9931,t
HP:0010271,Enlarged epiphyses of the proximal phalanges of the hand,HP:0010276,Small epiphyses of the proximal phalanges of the hand,0.9946,t
HP:0010306,Short thorax,HP:0100818,Long thorax,0.9777,t
HP:0010450,Esophageal stenosis,HP:6000589,Esophageal dilation,0.9689,t
HP:0010514,Hyperpituitarism,HP:0040075,Hypopituitarism,0.9643,t
HP:0010545,Downbeat nystagmus,HP:0011477,Upbeat nystagmus,0.9953,t
HP:0010570,Low maternal circulating alpha-fetoprotein concentration,HP:0011432,Elevated maternal circulating alpha-fetoprotein concentration,0.9904,t
HP:0010580,Enlarged epiphyses,HP:0010585,Small epiphyses,0.9759,t
HP:0010650,Hypoplasia of the premaxilla,HP:0430029,Hyperplasia of the premaxilla,0.9822,t
HP:0010669,Hypoplasia of the zygomatic bone,HP:0012370,Prominence of the zygomatic bone,0.9575,t
HP:0010763,Low insertion of columella,HP:0012807,High insertion of columella,0.9937,t
HP:0010779,Large pelvis bone,HP:0008839,Hypoplastic pelvis,0.9187,t
HP:0010790,Hypoplasia of the Leydig cells,HP:0010791,Hyperplasia of the Leydig cells,0.9840,t
HP:0010809,Broad uvula,HP:0010811,Narrow uvula,0.9488,t
HP:0010810,Long uvula,HP:0010812,Short uvula,0.9785,t
HP:0010837,Decreased circulating ceruloplasmin concentration,HP:0033145,Increased circulating ceruloplasmin concentration,0.9977,t
HP:0010860,Complete breech presentation,HP:0010861,Incomplete breech presentation,0.9825,t
HP:0010906,Hyperhistidinemia,HP:0500145,Hypohistidinemia,0.9714,t
HP:0010910,Hypervalinemia,HP:0500132,Hypovalinemia,0.9643,t
HP:0010911,Hyperleucinemia,HP:0500143,Hypoleucinemia,0.9713,t
HP:0010913,Hyperisoleucinemia,HP:0500144,Hypoisoleucinemia,0.9711,t
HP:0010964,Abnormal circulating long-chain fatty-acid concentration,HP:0033147,Abnormal circulating short-chain fatty-acid concentration,0.9958,f
HP:0010976,B lymphocytopenia,HP:0005404,Increased B cell count,0.8311,t
HP:0010980,Hyperlipoproteinemia,HP:0010981,Hypolipoproteinemia,0.9420,t
HP:0011009,Acute,HP:0011010,Chronic,0.8383,t
HP:0011037,Decreased urine output,HP:0000103,Polyuria,0.7836,f
HP:0011105,Hypervolemia,HP:0011106,Hypovolemia,0.9733,t
HP:0011173,Focal behavior arrest seizure,HP:0011174,Focal hyperkinetic seizure,0.8457,f
HP:0011238,Prominent inferior crus of antihelix,HP:0011239,Underdeveloped inferior crus of antihelix,0.9324,t
HP:0011246,Underdeveloped superior crus of antihelix,HP:0011247,Prominent superior crus of antihelix,0.9404,t
HP:0011271,Prominent tragus,HP:0011272,Underdeveloped tragus,0.8813,t
HP:0011284,Short-segment aganglionic megacolon,HP:0011285,Long-segment aganglionic megacolon,0.9965,f
HP:0011340,Incomplete cleft of the upper lip,HP:5201009,Complete cleft of the upper lip,0.9906,t
HP:0011383,Enlarged semicircular canal,HP:0011382,Hypoplasia of the semicircular canal,0.9343,t
HP:0011433,High maternal circulating chorionic gonadotropin concentration,HP:0011434,Low maternal circulating chorionic gonadotropin concentration,0.9979,t
HP:0011775,Thyroid macrofollicular adenoma,HP:0011776,Thyroid microfollicular adenoma,0.9923,f
HP:0011800,Midface retrusion,HP:0012371,Hyperplasia of midface,0.8388,f
HP:0011858,Reduced factor IX activity,HP:0033061,Increased factor IX activity,0.9730,t
HP:0011899,Hyperfibrinogenemia,HP:0011900,Hypofibrinogenemia,0.9717,t
HP:0011935,Decreased urinary urate,HP:0003149,Hyperuricosuria,0.8972,t
HP:0011967,Decreased circulating copper concentration,HP:0032254,Increased circulating copper concentration,0.9893,t
HP:0011972,Hypoglycorrhachia,HP:0031885,Hyperglycorrhachia,0.9778,t
HP:0011998,Postprandial hyperglycemia,HP:0012051,Reactive hypoglycemia,0.9152,t
HP:0012026,Hyperornithinemia,HP:0500163,Hypoornithinemia,0.9772,t
HP:0012052,Low serum calcitriol,HP:0031415,High serum calcitriol,0.9963,t
HP:0012053,Decreased circulating calcifediol concentration,HP:0031414,High serum calcifediol,0.9457,t
HP:0012081,Enlarged cerebellum,HP:0001321,Cerebellar hypoplasia,0.9279,t
HP:0012107,Increased fibular diameter,HP:0031107,Decreased fibular diameter,0.9946,t
HP:0012132,Erythroid hyperplasia,HP:0012133,Erythroid hypoplasia,0.9771,t
HP:0012138,Granulocytic hyperplasia,HP:0012139,Granulocytic hypoplasia,0.9784,t
HP:0012213,Decreased glomerular filtration rate,HP:0012214,Increased glomerular filtration rate,0.9951,t
HP:0012238,Increased circulating chylomicron concentration,HP:0031242,Decreased circulating chylomicron concentration,0.9969,t
HP:0012250,ST segment depression,HP:0012251,ST segment elevation,0.9624,t
HP:0012270,Decreased muscle glycogen content,HP:0009051,Increased muscle glycogen content,0.9951,t
HP:0012279,Hyposerinemia,HP:0500138,Hyperserinemia,0.9267,t
HP:0012311,Monocytosis,HP:0012312,Monocytopenia,0.9480,t
HP:0012340,Decreased resting energy expenditure,HP:0012339,Increased resting energy expenditure,0.9883,t
HP:0012341,Microprolactinoma,HP:0012342,Macroprolactinoma,0.9700,t
HP:0012350,Decreased sialylation of N-linked protein glycosylation,HP:0012351,Increased sialylation of N-linked protein glycosylation,0.9985,t
HP:0012353,Decreased fucosylation of N-linked protein glycosylation,HP:0012354,Increased fucosylation of N-linked protein glycosylation,0.9987,t
HP:0012356,Decreased mannosylation of N-linked protein glycosylation,HP:0012357,Increased mannosylation of N-linked protein glycosylation,0.9987,t
HP:0012360,Decreased fucosylation of O-linked protein glycosylation,HP:0012361,Increased fucosylation of O-linked protein glycosylation,0.9987,t
HP:0012364,Decreased urinary potassium,HP:0003081,Increased urinary potassium,0.9921,t
HP:0012392,Jaw hyporeflexia,HP:0033683,Jaw hyperreflexia,0.9758,t
HP:0012403,Decreased urine alpha-ketoglutarate concentration,HP:0012402,Increased urine alpha-ketoglutarate concentration,0.9982,t
HP:0012405,Hypocitraturia,HP:0012406,Hypercitraturia,0.9688,t
HP:0012416,Hypercapnia,HP:0012417,Hypocapnia,0.9532,t
HP:0012450,Chronic constipation,HP:0012451,Acute constipation,0.9571,f
HP:0012466,Chronic respiratory acidosis,HP:0012467,Acute respiratory acidosis,0.9353,f
HP:0012505,Enlarged pituitary gland,HP:0012506,Small pituitary gland,0.9804,t
HP:0012560,Decreased T3/T4 ratio,HP:0012559,Increased T3/T4 ratio,0.9944,t
HP:0012604,Hyponatriuria,HP:0012605,Hypernatriuria,0.9710,t
HP:0012608,Hypermagnesiuria,HP:0012609,Hypomagnesiuria,0.9761,t
HP:0012648,Decreased inflammatory response,HP:0012649,Increased inflammatory response,0.9762,t
HP:0012685,Decreased pineal volume,HP:0012686,Increased pineal volume,0.9951,t
HP:0012691,Focal T2 hypointense thalamic lesion,HP:0012692,Focal T2 hyperintense thalamic lesion,0.9914,t
HP:0012748,Focal T2 hyperintense brainstem lesion,HP:0012749,Focal T2 hypointense brainstem lesion,0.9908,t
HP:0012755,Enlarged brainstem,HP:0002365,Hypoplasia of the brainstem,0.8845,t
HP:0012770,Reduced arm span,HP:0012771,Increased arm span,0.9621,t
HP:0012773,Reduced upper to lower segment ratio,HP:0012774,Increased upper to lower segment ratio,0.9854,t
HP:0012801,Narrow jaw,HP:0012802,Broad jaw,0.9410,t
HP:0012809,Narrow nasal base,HP:0012810,Wide nasal base,0.9721,t
HP:0012858,Decreased scrotal rugation,HP:0012857,Increased scrotal rugation,0.9943,t
HP:0020060,Decreased red blood cell count,HP:0020059,Increased red blood cell count,0.9878,t
HP:0020062,Decreased hemoglobin concentration,HP:0001900,Increased circulating hemoglobin concentration,0.9732,t
HP:0020112,Increased proportion of CD4+CD25+ regulatory T cells,HP:0020113,Decreased proportion of CD4+CD25+ regulatory T cells,0.9987,t
HP:0020141,Blood pressure substantially higher in legs than arms,HP:0020142,Blood pressure substantially higher in arms than legs,0.9981,t
HP:0020170,Increased blood drug concentration,HP:0020171,Decreased blood drug concentration,0.9864,t
HP:0020184,Decreased circulating A-type natriuretic peptide concentration,HP:0020183,Increased circulating A-type natriuretic peptide concentration,0.9980,t
HP:0020199,Decreased circulating 18-hydroxycortisone level,HP:0020200,Increased circulating 18-hydroxycortisone level,0.9972,t
HP:0020285,Decreased lymph node lymphocyte cytoplasm,HP:0020286,Increased lymph node lymphocyte cytoplasm,0.9967,t
HP:0020292,Decreased lymph-node cellular CD20 expression,HP:0020291,Increased lymph-node cellular CD20 expression,0.9977,t
HP:0020293,Decreased lymph-node cellular CD19 expression,HP:0020294,Increased lymph-node cellular CD19 expression,0.9977,t
HP:0025066,Decreased mean corpuscular volume,HP:0005518,Increased mean corpuscular volume,0.9929,t
HP:0025077,Decreased QRS voltage,HP:0025075,Increased QRS voltage,0.9896,t
HP:0025090,Abnormal large intestinal mucosa morphology,HP:0025129,Abnormal small intestinal mucosa morphology,0.9972,f
HP:0025137,Decreased serum estriol,HP:0025136,Increased serum estriol,0.9948,t
HP:0025140,Decreased serum estrone,HP:0025139,Increased serum estrone,0.9894,t
HP:0025158,Hyperautofluorescent retinal lesion,HP:0025159,Hypoautofluorescent retinal lesion,0.9900,t
HP:0025250,Closed comedo,HP:0025251,Open comedo,0.9760,t
HP:0025330,Downgaze palsy,HP:0025331,Upgaze palsy,0.9951,t
HP:0025346,Increased circulating beta-2-microglobulin level,HP:0025347,Decreased circulating beta-2-microglobulin level,0.9975,t
HP:0025434,Reduced circulating CH50 activity,HP:0031905,Increased total hemolytic complement activity,0.8865,t
HP:0025435,Increased circulating lactate dehydrogenase concentration,HP:0045041,Reduced circulating lactate dehydrogenase concentration,0.9964,t
HP:0025437,Macrozoospermia,HP:0032561,Microcephalic sperm head,0.8138,f
HP:0025458,Decreased CSF albumin concentration,HP:0500239,Increased CSF albumin concentration,0.9962,t
HP:0025547,Decreased mean corpuscular hemoglobin concentration,HP:0025548,Increased mean corpuscular hemoglobin concentration,0.9975,t
HP:0025584,Hypotropia,HP:0025586,Hypertropia,0.8498,t
HP:0025585,Hyperphoria,HP:0031725,Hypophoria,0.9154,t
HP:0025587,Hyperdeviation,HP:0025588,Hypodeviation,0.9358,t
HP:0025622,obsolete Decreased proportion of CD4+ central memory cells,HP:0025621,obsolete Increased proportion of CD4+ central memory cells,0.9976,t
HP:0025624,Reduced proportion of CD4+ effector memory T cells,HP:0410394,"Increased proportion of effector memory CD4-positive, alpha-beta T cells",0.9636,f
HP:0025624,Reduced proportion of CD4+ effector memory T cells,HP:0025625,Elevated proportion of CD4+ effector memory T cells,0.9941,t
HP:0025648,Steroid-sensitive nephrotic syndrome with infrequent relapses,HP:0025649,Steroid-sensitive nephrotic syndrome with frequent relapses,0.9873,t
HP:0025684,Decreased amyloid beta 42 peptide CSF concentration,HP:0025685,Increased amyloid beta 42 peptide CSF concentration,0.9980,t
HP:0025693,Pituitary macroadenoma,HP:0025694,Pituitary microadenoma,0.9606,t
HP:0025708,Early young adult onset,HP:0025710,Late young adult onset,0.9951,t
HP:0025759,Mobile lump,HP:0025760,Immobile lump,0.8579,t
HP:0025767,Abnormal positive emotional state,HP:0031467,Abnormal negative emotional state,0.9890,t
HP:0030018,Decreased female libido,HP:0030019,Increased female libido,0.9873,t
HP:0030050,Narcolepsy,HP:0100785,Insomnia,0.8718,t
HP:0030088,Increased serum testosterone level,HP:0040171,Decreased serum testosterone concentration,0.9865,t
HP:0030143,Hyperactive bowel sounds,HP:0030144,Hypoactive bowel sounds,0.9763,t
HP:0030255,Large intestinal polyposis,HP:0030256,Small intestinal polyposis,0.9933,f
HP:0030258,Hyperpigmented genitalia,HP:0030259,Hypopigmented genitalia,0.9627,t
HP:0030339,Decreased circulating gonadotropin concentration,HP:0000837,Increased circulating gonadotropin level,0.9919,t
HP:0030341,Decreased circulating follicle stimulating hormone concentration,HP:0008232,Elevated circulating follicle stimulating hormone level,0.9888,t
HP:0030344,Decreased circulating luteinizing hormone level,HP:0011969,Elevated circulating luteinizing hormone level,0.9893,t
HP:0030349,Decreased circulating androgen concentration,HP:0030348,Increased circulating androgen concentration,0.9922,t
HP:0030353,Decreased serum insulin-like growth factor 1,HP:0030269,Increased circulating insulin-like growth factor 1 concentration,0.9749,t
HP:0030360,Large cell lung carcinoma,HP:0030357,Small cell lung carcinoma,0.9915,t
HP:0030372,Decreased proportion of naive B cells,HP:0030371,Increased proportion of naive B cells,0.9941,t
HP:0030374,Decreased proportion of memory B cells,HP:0030375,Increased proportion of memory B cells,0.9949,t
HP:0030378,Decreased proportion of immature B cells,HP:0030377,Increased proportion of immature B cells,0.9966,t
HP:0030380,Decreased proportion of transitional B cells,HP:0030381,Increased proportion of transitional B cells,0.9942,t
HP:0030384,Decreased proportion of marginal zone B cells,HP:0030385,Increased proportion of marginal zone B cells,0.9965,t
HP:0030388,Decreased proportion of class-switched memory B cells,HP:0030387,Increased proportion of class-switched memory B cells,0.9969,t
HP:0030607,Reduced OCT-measured macular thickness,HP:0030608,Increased OCT-measured macular thickness,0.9931,t
HP:0030618,Increased OCT-measured foveal thickness,HP:0030619,Reduced OCT-measured foveal thickness,0.9932,t
HP:0030631,Hyperautofluorescent macular lesion,HP:0030632,Hypoautofluorescent macular lesion,0.9905,t
HP:0030633,Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence,HP:0030634,Perifoveal ring of hyperautofluorescence surrounded by abnormal autofluorescence,0.9960,t
HP:0030638,Congenital stationary night blindness with normal fundus,HP:0030639,Congenital stationary night blindness with abnormal fundus,0.9963,f
HP:0030640,Complete congenital stationary night blindness,HP:0030641,Incomplete congenital stationary night blindness,0.9940,f
HP:0030685,Decreased adiponectin level,HP:0030686,Increased adiponectin level,0.9960,t
HP:0030689,Decreased glucagon level,HP:0030688,Increased glucagon level,0.9945,t
HP:0030783,Increased circulating interleukin 6 concentration,HP:0430142,Reduced circulating interleukin 6 concentration,0.9942,t
HP:0030795,Reduced C-peptide level,HP:0030796,Increased C-peptide level,0.9921,t
HP:0030851,Low pulse pressure,HP:0030852,High pulse pressure,0.9885,t
HP:0030897,Decreased intestinal transit time,HP:0410204,Increased intestinal transit time,0.9930,t
HP:0030978,Decreased CSF/serum albumin ratio,HP:0025459,Increased CSF/serum albumin ratio,0.9964,t
HP:0030985,Decreased serum bile acid concentration,HP:0012202,Increased serum bile acid concentration,0.9951,t
HP:0031085,Decreased circulating prealbumin concentration,HP:0033451,Increased circulating prealbumin concentration,0.9955,t
HP:0031098,Decreased thyroid-stimulating hormone level,HP:0002925,Elevated circulating thyroid-stimulating hormone concentration,0.9746,t
HP:0031100,Decreased circulating inhibin B concentration,HP:6000520,Increased circulating inhibin B concentration,0.9961,t
HP:0031103,Decreased circulating antimullerian hormone circulation,HP:0031102,Increased circulating antimullerian hormone concentration,0.9847,t
HP:0031141,Increased hepatic echogenicity,HP:0031143,Decreased hepatic echogenicity,0.9934,t
HP:0031209,Decreased circulating lipoprotein lipase concentration,HP:0033478,Increased circulating lipoprotein lipase concentration,0.9947,t
HP:0031214,Decreased circulating dehydroepiandrosterone concentration,HP:0034908,Increased circulating dehydroepiandrosterone concentration,0.9983,t
HP:0031215,Decreased circulating dehydroepiandrosterone-sulfate concentration,HP:0034589,Increased circulating dehydroepiandrosterone-sulfate concentration,0.9988,t
HP:0031219,Reduced radioactive iodine uptake,HP:0031220,Increased radioactive iodine uptake,0.9935,t
HP:0031222,Increased circulating thyroxine-binding globulin level,HP:0034591,Decreased circulating thyroxine-binding globulin concentration,0.9946,t
HP:0031230,Decreased incisura length,HP:0031229,Increased incisura length,0.9932,t
HP:0031243,Decreased VLDL cholesterol concentration,HP:0003362,Increased VLDL cholesterol concentration,0.9948,t
HP:0031245,Productive cough,HP:0031246,Nonproductive cough,0.8559,t
HP:0031385,Megakaryocyte nucleus hypolobulation,HP:0031388,Megakaryocyte nucleus hyperlobulation,0.9760,t
HP:0031397,Decreased proportion of naive T cells,HP:0031398,Increased proportion of naive T cells,0.9947,t
HP:0031413,Short telomere length,HP:6000036,Long telomere length,0.9916,t
HP:0031426,Decreased circulating beta-C-terminal telopeptide concentration,HP:0031425,Increased circulating beta-C-terminal telopeptide concentration,0.9978,t
HP:0031429,Decreased circulating osteocalcin level,HP:0031428,Increased circulating osteocalcin level,0.9919,t
HP:0031507,Decreased circulating T4 concentration,HP:0031506,Increased circulating T4 concentration,0.9890,t
HP:0031594,PR segment depression,HP:0031597,PR segment elevation,0.9709,t
HP:0031808,Decreased basophil count,HP:0031807,Increased basophil count,0.9952,t
HP:0031817,Decreased circulating parathyroid hormone level,HP:0003165,Elevated circulating parathyroid hormone level,0.9891,t
HP:0031820,Decreased waist to hip ratio,HP:0031819,Increased waist to hip ratio,0.9903,t
HP:0031831,Decreased serum zinc,HP:0011424,Increased serum zinc,0.9852,t
HP:0031837,Decreased circulating superoxide dismutase concentration,HP:0031836,Increased circulating superoxide dismutase concentration,0.9964,t
HP:0031843,Abnormally slow thought process,HP:0033844,Racing thoughts,0.8251,t
HP:0031861,Decreased heart rate variability,HP:0031862,Increased heart rate variability,0.9864,t
HP:0031873,Early chronotype,HP:0031874,Late chronotype,0.9930,t
HP:0031937,Tachylalia,HP:5200038,Bradylalia,0.9661,t
HP:0031997,Early inspiratory crackles,HP:0031998,Late inspiratory crackles,0.9977,t
HP:0032097,Hypermanganesemia,HP:0032098,Hypomanganesemia,0.9738,t
HP:0032125,Increased proportion of unswitched memory B cells,HP:0032126,Decreased proportion of unswitched memory B cells,0.9967,t
HP:0032129,Decreased proportion of plasmablasts,HP:0032128,Increased proportion of plasmablasts,0.9935,t
HP:0032136,Decreased circulating IgG1 concentration,HP:0032298,Increased circulating IgG1 level,0.9837,t
HP:0032137,Decreased circulating IgG3 concentration,HP:0032297,Increased circulating IgG3 level,0.9791,t
HP:0032138,Decreased circulating IgG4 concentration,HP:0032300,Increased circulating IgG4 level,0.9852,t
HP:0032164,Increased blood folate concentration,HP:0100507,Reduced blood folate concentration,0.9897,t
HP:0032183,Decreased proportion of memory T cells,HP:0032184,Increased proportion of memory T cells,0.9943,t
HP:0032198,Decreased prothrombin time,HP:0008151,Prolonged prothrombin time,0.9668,t
HP:0032210,Decreased circulating free T3,HP:0011788,Increased circulating free T3,0.9910,t
HP:0032218,Decreased proportion of CD4-positive T cells,HP:0032219,Increased proportion of CD4-positive T cells,0.9972,t
HP:0032305,Decreased circulating mannose-binding protein concentration,HP:0032306,Increased circulating mannose-binding protein concentration,0.9957,t
HP:0032312,Decreased circulating globulin level,HP:0032311,Increased circulating globulin level,0.9946,t
HP:0032363,Decreased circulating corticosterone level,HP:0032362,Increased circulating corticosterone level,0.9956,t
HP:0032421,Decreased HDL2a concentration,HP:0032420,Increased HDL2a concentration,0.9937,t
HP:0032423,Decreased HDL2b concentration,HP:0032424,Increased HDL2b concentration,0.9925,t
HP:0032429,Decreased HDL3a concentration,HP:0032428,Increased HDL3a concentration,0.9941,t
HP:0032431,Decreased HDL3b concentration,HP:0032430,Increased HDL3b concentration,0.9938,t
HP:0032433,Decreased HDL3c concentration,HP:0032432,Increased HDL3c concentration,0.9925,t
HP:0032460,Decreased phosphoribosylpyrophosphate synthetase level,HP:0003240,Increased phosphoribosylpyrophosphate synthetase level,0.9990,t
HP:0032473,Decreased urine urobilinogen,HP:0031890,Increased urine urobilinogen,0.9972,t
HP:0032482,Decreased pituitary glycoprotein hormone alpha subunit level,HP:0031208,Increased pituitary glycoprotein hormone alpha subunit level,0.9987,t
HP:0032489,Elevated fecal pH,HP:0032490,Decreased fecal pH,0.9651,t
HP:0032675,Acute cutaneous wound,HP:0032676,Chronic cutaneous wound,0.9574,t
HP:0032994,Supernumerary pulmonary fissure,HP:0032995,Decreased pulmonary fissure count,0.9357,t
HP:0032997,Decreased cystatin C level,HP:0032998,Increased cystatin C level,0.9963,t
HP:0033014,Decreased salivary cortisol level,HP:0033015,Increased salivary cortisol level,0.9973,t
HP:0033078,Decreased circulating free T4 concentration,HP:0033077,Increased circulating free T4 concentration,0.9945,t
HP:0033085,Reduced antral follicle count,HP:0033086,Increased antral follicle count,0.9903,t
HP:0033192,Decreased circulating selenium concentration,HP:0033191,Increased circulating selenium concentration,0.9940,t
HP:0033199,Increased circulating interleukin 10 concentration,HP:0034163,Reduced circulating interleukin 10 concentration,0.9945,t
HP:0033200,Triceps hyporeflexia,HP:0033204,Triceps hyperreflexia,0.9835,t
HP:0033201,Biceps hyporeflexia,HP:0033205,Biceps hyperreflexia,0.9819,t
HP:0033202,Brachioradialis hyporeflexia,HP:0033203,Brachioradialis hyperreflexia,0.9870,t
HP:0033211,Decreased total iron binding capacity,HP:0025196,Increased total iron binding capacity,0.9915,t
HP:0033222,Decreased CD4:CD8 ratio,HP:0033221,Increased CD4:CD8 ratio,0.9961,t
HP:0033299,Reduced circulating complement factor H related protein 1 concentration,HP:0033300,Increased circulating complement factor H related protein 1 concentration,0.9954,t
HP:0033306,Decreased circulating fetuin A concentration,HP:0033307,Increased circulating fetuin A concentration,0.9961,t
HP:0033374,Decreased KCO,HP:0033373,Increased KCO,0.9915,t
HP:0033449,Decreased mid-arm muscle circumference,HP:0033448,Increased mid-arm muscle circumference,0.9958,t
HP:0033507,Decreased esterified to free carnitine ratio,HP:0033506,Increased esterified to free carnitine ratio,0.9979,t
HP:0033531,Decreased cardiac index,HP:0033530,Increased cardiac index,0.9760,t
HP:0033532,Decreased cardiac output,HP:0033533,Increased cardiac output,0.9849,t
HP:0033633,Decreased alveolar volume,HP:0033634,Increased alveolar volume,0.9927,t
HP:0033687,Short term memory impairment,HP:0033688,Long term memory impairment,0.9962,f
HP:0033733,Low-grade vesicoureteral reflux,HP:0033734,High-grade vesicoureteral reflux,0.9964,t
HP:0033748,Hypoesthesia,HP:0100963,Hyperesthesia,0.9300,t
HP:0033756,Decreased left ventricular end-diastolic volume,HP:0033755,Increased left ventricular end-diastolic volume,0.9961,t
HP:0033765,Death in late adulthood,HP:0100613,Death in early adulthood,0.9931,f
HP:0033812,Decreased circulating androstenedione concentration,HP:0025380,Increased circulating androstenedione concentration,0.9956,t
HP:0033908,Renal arteriole medial atrophy,HP:0033918,Renal arteriole medial hypertrophy,0.9679,t
HP:0033909,Arcuate vein medial hypertrophy,HP:0033910,Arcuate vein medial atrophy,0.9562,t
HP:0033911,Cortical radial artery medial hypertrophy,HP:0033912,Cortical radial artery medial atrophy,0.9681,t
HP:0033972,Interlobular vein medial atrophy,HP:0033973,Interlobular vein medial hypertrophy,0.9627,t
HP:0033985,Elongated femoral neck,HP:0100864,Short femoral neck,0.9788,t
HP:0034073,Reduced fetal long bone echogenicity,HP:0034074,Increased fetal long bone echogenicity,0.9933,t
HP:0034165,Reduced circulating interleukin 21 concentration,HP:0034166,Increased circulating interleukin 21 concentration,0.9931,t
HP:0034168,Reduced circulating interleukin 22 concentration,HP:0034169,Increased circulating interleukin 22 concentration,0.9937,t
HP:0034171,Reduced circulating interleukin 23 concentration,HP:0034172,Increased circulating interleukin 23 concentration,0.9935,t
HP:0034174,Reduced circulating interleukin 27 concentration,HP:0034175,Increased circulating interleukin 27 concentration,0.9931,t
HP:0034177,Reduced circulating interleukin 17A concentration,HP:0034178,Increased circulating interleukin 17A concentration,0.9952,t
HP:0034184,Increased insulin like growth factor binding protein acid labile subunit concentration,HP:0045046,Reduced insulin like growth factor binding protein acid labile subunit concentration,0.9969,t
HP:0034203,Decreased iduronate sulfatase level,HP:0003538,Increased iduronate sulfatase level,0.9976,t
HP:0034237,Open neural tube defect,HP:0034238,Closed neural tube defect,0.9895,t
HP:0034390,Decreased CSF glycine concentration,HP:0500230,Increased CSF glycine concentration,0.9964,t
HP:0034441,Decreased circulating aspartic acid concentration,HP:0500159,Increased circulating aspartic acid concentration,0.9952,t
HP:0034449,Increased phytanic acid:pristanic acid ratio,HP:0034450,Decreased phytanic acid:pristanic acid ratio,0.9983,t
HP:0034487,Increased circulating interleukin 12 concentration,HP:6000487,Reduced circulating interleukin 12 concentration,0.9937,t
HP:0034712,Decreased circulating alpha-mannosidase activity,HP:4000191,Increased circulating alpha-mannosidase activity,0.9964,t
HP:0034740,Reduced CSF methionine concentration,HP:0500210,Increased CSF methionine concentration,0.9960,t
HP:0034792,Decreased muscle succinate dehydrogenase staining,HP:0034791,Increased muscle succinate dehydrogenase staining,0.9980,t
HP:0035015,Elevated circulating short-chain acylcarnitine concentration,HP:0035018,Elevated circulating long-chain acylcarnitine concentration,0.9976,f
HP:0040013,Decreased mitochondrial number,HP:0040014,Increased mitochondrial number,0.9845,t
HP:0040030,Chorioretinal hypopigmentation,HP:0040031,Chorioretinal hyperpigmentation,0.9656,t
HP:0040053,Long lower eyelashes,HP:0040055,Short lower eyelashes,0.9912,t
HP:0040063,Decreased adipose tissue,HP:0009126,Increased adipose tissue,0.9898,t
HP:0040179,Decreased level of platelet-activating factor,HP:0040178,Increased level of platelet-activating factor,0.9959,t
HP:0040195,Decreased head circumference,HP:0040194,Increased head circumference,0.9936,t
HP:0040254,Decreased size of the clitoris,HP:0040253,Increased size of the clitoris,0.9933,t
HP:0040260,Decreased size of nasopharyngeal adenoids,HP:0040261,Increased size of nasopharyngeal adenoids,0.9981,t
HP:0040275,Adenocarcinoma of the large intestine,HP:0040274,Adenocarcinoma of the small intestine,0.9979,f
HP:0040299,Decreased circulating free fatty acid level,HP:0030781,Increased circulating free fatty acid level,0.9945,t
HP:0040303,Decreased circulating iron concentration,HP:0003452,Increased circulating iron concentration,0.9905,t
HP:0040306,Decreased male libido,HP:0040305,Increased male libido,0.9858,t
HP:0040309,Increased size of the mandible,HP:0000347,Micrognathia,0.7744,t
HP:0040328,Focal hyperintensity of cerebral white matter on MRI,HP:0040331,Focal hypointensity of cerebral white matter on MRI,0.9831,t
HP:0040329,Multifocal hyperintensity of cerebral white matter on MRI,HP:0040332,Multifocal hypointensity of cerebral white matter on MRI,0.9865,t
HP:0040330,Confluent hyperintensity of cerebral white matter on MRI,HP:0040333,Confluent hypointensity of cerebral white matter on MRI,0.9855,t
HP:0040426,Decreased urinary hypoxanthine level,HP:0011814,Increased urinary hypoxanthine level,0.9962,t
HP:0041078,Decreased immunoglobulin level in body fluid,HP:0041077,Increased immunoglobulin level in body fluid,0.9974,t
HP:0041079,Decreased body fat percentage,HP:0025521,Increased body fat percentage,0.9850,t
HP:0045011,Decreased urine bicarbonate concentration,HP:0003646,Bicarbonaturia,0.9201,f
HP:0045035,Decreased urinary copper concentration,HP:0010839,Increased urinary copper concentration,0.9940,t
HP:0045051,Decreased DLCO,HP:0045050,Increased DLCO,0.9906,t
HP:0045082,Decreased body mass index,HP:0031418,Increased body mass index,0.9884,t
HP:0046504,Decreased libido,HP:0046503,Increased libido,0.9825,t
HP:0100047,Enlarged epiphyses of the 2nd toe,HP:0100052,Small epiphyses of the 2nd toe,0.9882,t
HP:0100058,Enlarged epiphyses of the 3rd toe,HP:0100063,Small epiphyses of the 3rd toe,0.9880,t
HP:0100069,Enlarged epiphyses of the 4th toe,HP:0100074,Small epiphyses of the 4th toe,0.9876,t
HP:0100080,Enlarged epiphyses of the 5th toe,HP:0100085,Small epiphyses of the 5th toe,0.9884,t
HP:0100103,Enlarged epiphysis of the distal phalanx of the 2nd toe,HP:0100108,Small epiphysis of the distal phalanx of the 2nd toe,0.9953,t
HP:0100114,Enlarged epiphysis of the middle phalanx of the 2nd toe,HP:0100119,Small epiphysis of the middle phalanx of the 2nd toe,0.9945,t
HP:0100125,Enlarged epiphysis of the proximal phalanx of the 2nd toe,HP:0100130,Small epiphysis of the proximal phalanx of the 2nd toe,0.9953,t
HP:0100138,Enlarged epiphysis of the distal phalanx of the 3rd toe,HP:0100143,Small epiphysis of the distal phalanx of the 3rd toe,0.9951,t
HP:0100149,Enlarged epiphysis of the middle phalanx of the 3rd toe,HP:0100154,Small epiphysis of the middle phalanx of the 3rd toe,0.9942,t
HP:0100160,Enlarged epiphysis of the proximal phalanx of the 3rd toe,HP:0100165,Small epiphysis of the proximal phalanx of the 3rd toe,0.9951,t
HP:0100172,Enlarged epiphysis of the distal phalanx of the 4th toe,HP:0100177,Small epiphysis of the distal phalanx of the 4th toe,0.9950,t
HP:0100183,Enlarged epiphysis of the middle phalanx of the 4th toe,HP:0100188,Small epiphysis of the middle phalanx of the 4th toe,0.9942,t
HP:0100194,Enlarged epiphysis of the proximal phalanx of the 4th toe,HP:0100199,Small epiphysis of the proximal phalanx of the 4th toe,0.9951,t
HP:0100205,Enlarged epiphysis of the distal phalanx of the 5th toe,HP:0100210,Small epiphysis of the distal phalanx of the 5th toe,0.9952,t
HP:0100216,Enlarged epiphysis of the middle phalanx of the 5th toe,HP:0100221,Small epiphysis of the middle phalanx of the 5th toe,0.9944,t
HP:0100227,Enlarged epiphysis of the proximal phalanx of the 5th toe,HP:0100232,Small epiphysis of the proximal phalanx of the 5th toe,0.9952,t
HP:0100281,Chronic colitis,HP:0100282,Acute colitis,0.9610,f
HP:0100293,Hypertrophied muscle fibers,HP:0100295,Muscle fiber atrophy,0.8648,t
HP:0100513,Decreased circulating vitamin E concentration,HP:0034901,Increased circulating vitamin E concentration,0.9939,t
HP:0100553,Hemihypertrophy of lower limb,HP:0200053,Hemihypotrophy of lower limb,0.9566,t
HP:0100554,Hemihypertrophy of upper limb,HP:0100558,Hemiatrophy of upper limb,0.9735,t
HP:0100625,Enlarged thorax,HP:0005257,Thoracic hypoplasia,0.8325,t
HP:0100689,Decreased corneal thickness,HP:0011487,Increased corneal thickness,0.9903,t
HP:0100736,Abnormal soft palate morphology,HP:0100737,Abnormal hard palate morphology,0.9898,f
HP:0100770,Hyperperistalsis,HP:0100771,Hypoperistalsis,0.8231,t
HP:0100834,Neoplasm of the large intestine,HP:0100833,Neoplasm of the small intestine,0.9978,f
HP:0100878,Enlarged uterus,HP:0000013,Hypoplasia of the uterus,0.9003,t
HP:0100961,Enlarged hippocampus,HP:0025517,Hypoplastic hippocampus,0.9396,t
HP:0200119,Acute hepatitis,HP:0200123,Chronic hepatitis,0.9615,t
HP:0400004,Long ear,HP:0400005,Short ear,0.9649,t
HP:0410054,Decreased circulating GABA concentration,HP:0410053,Elevated circulating gamma-aminobutyric acid concentration,0.8844,t
HP:0410145,Decreased circulating biotinidase concentration,HP:0410146,Elevated circulating biotinidase concentration,0.9818,t
HP:0410179,Decreased glucose-6-phosphate dehydrogenase level in blood,HP:0410178,Increased glucose-6-phosphate dehydrogenase level in blood,0.9979,t
HP:0410182,Decreased glucose-6-phosphate dehydrogenase level in dried blood spot,HP:0410181,Increased glucose-6-phosphate dehydrogenase level in dried blood spot,0.9986,t
HP:0410187,Decreased glucose-6-phosphate dehydrogenase level in tissue,HP:0410186,Increased glucose-6-phosphate dehydrogenase level in tissue,0.9976,t
HP:0410188,Decreased glucose-6-phosphate dehydrogenase level in red blood cells,HP:0410189,Increased glucose-6-phosphate dehydrogenase level in red blood cells,0.9980,t
HP:0410190,Decreased glucose-6-phosphate dehydrogenase level in leukocytes,HP:0410191,Increased glucose-6-phosphate dehydrogenase level in leukocytes,0.9979,t
HP:0410195,Decreased circulating UDP glucose-4-epimerase concentration,HP:0410194,Increased circulating UDP glucose-4-epimerase concentration,0.9976,t
HP:0410198,Decreased erythrocyte UDP glucose-4-epimerase concentration,HP:0410197,Increased erythrocyte UDP glucose-4-epimerase concentration,0.9987,t
HP:0410212,Hyperoxemia in cord blood,HP:0410213,Hypoxemia in cord blood,0.9753,t
HP:0410214,Hypercapnia in cord blood,HP:0410215,Hypocapnia in cord blood,0.9763,t
HP:0410245,Decreased circulating IgD concentration,HP:0410246,Increased circulating IgD concentration,0.9931,t
HP:0410257,Neutrophilia in presence of infection,HP:0410258,Neutrophilia in absence of infection,0.9883,f
HP:0410288,Hyperamylasemia,HP:0410289,Hypoamylasemia,0.9726,t
HP:0410311,Hyposegmentation of neutrophil nuclei in CSF,HP:0410312,Hypersegmentation of neutrophil nuclei in CSF,0.9901,t
HP:0410314,Decreased urinary 1-methylhistidine,HP:0410315,Increased urinary 1-methylhistidine,0.9972,t
HP:0410318,Decreased urinary 3-methylhistidine,HP:0410317,Increased urinary 3-methylhistidine,0.9971,t
HP:0410343,Decreased circulating heparan sulfate level,HP:0410342,Increased circulating heparan sulfate level,0.9955,t
HP:0410353,Decreased complex N-glycan level,HP:0410352,Increased complex N-glycan level,0.9972,t
HP:0410355,Decreased sialylated N-glycan level,HP:0410354,Increased sialylated N-glycan level,0.9975,t
HP:0410358,Decreased high-mannose N-glycan level,HP:0410357,Increased high-mannose N-glycan level,0.9976,t
HP:0410361,Decreased core 1 O-glycan level,HP:0410360,Increased core 1 O-glycan level,0.9973,t
HP:0410364,Decreased monosialylated core 1 O-glycan level,HP:0410363,Increased monosialylated core 1 O-glycan level,0.9987,t
HP:0410375,Increased proportion of naive CD4 T cells,HP:0410378,Decreased proportion of naive CD4 T cells,0.9970,t
HP:0410376,Increased proportion of naive CD8 T cells,HP:0410377,Decreased proportion of naive CD8 T cells,0.9969,t
HP:0410385,"Decreased proportion of CD8-positive, alpha-beta memory T cells",HP:0410392,"Increased proportion of CD8-positive, alpha-beta memory T cells",0.9984,t
HP:0410386,"Decreased proportion of CD4-positive, alpha-beta memory T cells",HP:0410391,"Increased proportion of CD4-positive, alpha-beta memory T cells",0.9984,t
HP:0410388,"Decreased proportion of central memory CD4-positive, alpha-beta T cells",HP:0410393,"Increased proportion of central memory CD4-positive, alpha-beta T cells",0.9987,t
HP:0410389,"Decreased proportion of central memory CD8-positive, alpha-beta T cells",HP:0410396,"Increased proportion of central memory CD8-positive, alpha-beta T cells",0.9987,t
HP:0410390,"Decreased proportion of effector memory CD8-positive, alpha-beta T cells",HP:0410395,"Increased proportion of effector memory CD8-positive, alpha-beta T cells",0.9989,t
HP:0430047,Large joint hypermobilty,HP:0430046,Small joint hypermobilty,0.9940,f
HP:0430073,Decreased circulating beta-carotene concentration,HP:0430074,Increased circulating beta-carotene concentration,0.9966,t
HP:0500076,Alternating hypertropia,HP:0500078,Alternating hypotropia,0.8637,t
HP:0500077,Alternating hyperphoria,HP:0500079,Alternating hypophoria,0.9226,t
HP:0500134,Hypertryptophanemia,HP:0500135,Hypotryptophanemia,0.9516,t
HP:0500149,Hyperglutamatemia,HP:0500150,Hypoglutamatemia,0.9763,t
HP:0500151,Hypercystinemia,HP:0500152,Hypocystinemia,0.9686,t
HP:0500156,Hyperasparaginemia,HP:0500157,Hypoasparaginemia,0.9753,t
HP:0500161,Increased circulating carnosine concentration,HP:0500162,Decreased circulating carnosine concentration,0.9945,t
HP:0500181,Hypertaurinemia,HP:0500182,Hypotaurinemia,0.9553,t
HP:0500187,Increased CSF valine concentration,HP:0500188,Decreased CSF valine concentration,0.9974,t
HP:0500190,Decreased CSF leucine concentration,HP:0500191,Increased CSF leucine concentration,0.9968,t
HP:0500193,Increased CSF isoleucine concentration,HP:0500194,Decreased CSF isoleucine concentration,0.9966,t
HP:0500197,Increased CSF glutamine concentration,HP:0500198,Decreased CSF glutamine concentration,0.9967,t
HP:0500200,Increased CSF glutamate concentration,HP:0500201,Decreased CSF glutamate concentration,0.9968,t
HP:0500203,Increased CSF arginine concentration,HP:0500204,Decreased CSF arginine concentration,0.9965,t
HP:0500207,Decreased CSF lysine concentration,HP:0500208,Increased CSF lysine concentration,0.9961,t
HP:0500213,Decreased CSF threonine concentration,HP:0500212,Increased CSF threonine concentration,0.9971,t
HP:0500221,Decreased CSF tyrosine concentration,HP:0500220,Increased CSF tyrosine concentration,0.9971,t
HP:0500223,Increased CSF phenylalanine concentration,HP:0500224,Decreased CSF phenylalanine concentration,0.9971,t
HP:0500227,Increased CSF serine concentration,HP:0500228,Decreased CSF serine concentration,0.9957,t
HP:0500233,Increased CSF alanine concentration,HP:0500234,Decreased CSF alanine concentration,0.9971,t
HP:0500236,Increased CSF histidine concentration,HP:0500237,Decreased CSF histidine concentration,0.9959,t
HP:0500266,"Decreased proportion of CD8-positive, alpha-beta TEMRA T cells",HP:0500265,"Increased proportion of CD8-positive, alpha-beta TEMRA T cells",0.9986,t
HP:0500270,Increased proportion of gamma-delta T cells,HP:0500271,Decreased proportion of gamma-delta T cells,0.9963,t
HP:0500273,Increased proportion of immature gamma-delta T cells,HP:0500274,Decreased proportion of immature gamma-delta T cells,0.9978,t
HP:4000050,Open fracture,HP:4000051,Closed fracture,0.9790,t
HP:4000158,Typified by high penetrance,HP:4000160,Typified by low penetrance,0.9958,t
HP:5200320,Diminishment of relationship seeking,HP:5200315,Amplification of relationship seeking,0.9398,t
HP:5200321,Amplification of sexual behavior,HP:5200327,Diminishment of sexual behavior,0.9248,t
HP:5200328,Diminishment of emotional expression,HP:5200322,Amplification of emotional expression,0.9318,t
HP:5201000,Incomplete unilateral cleft lip,HP:5201001,Complete unilateral cleft lip,0.9917,t
HP:5201003,Complete cleft hard palate,HP:5201004,Incomplete cleft hard palate,0.9938,t
HP:5201003,Complete cleft hard palate,HP:5201005,Complete cleft soft palate,0.9909,f
HP:5201004,Incomplete cleft hard palate,HP:5201006,Incomplete cleft soft palate,0.9893,f
HP:5201005,Complete cleft soft palate,HP:5201006,Incomplete cleft soft palate,0.9933,t
HP:5201007,Incomplete cleft maxillary alveolar ridge,HP:5201008,Complete cleft maxillary alveolar ridge,0.9962,t
HP:5201011,Complete bilateral cleft lip,HP:5201012,Incomplete bilateral cleft lip,0.9875,t
HP:6000126,Decreased urinary bile acid level,HP:6000523,Increased urinary bile acid level,0.9961,t
HP:6000244,Decreased circulating thyroglobulin concentration,HP:0025484,Increased circulating thyroglobulin concentration,0.9959,t
HP:6000674,Decreased CSF N-acetylaspartic acid concentration,HP:0032274,Increased CSF N-acetylaspartic acid concentration,0.9978,t
HP:6000680,Low serum osmolality,HP:6000681,High serum osmolality,0.9946,t
HP:6000885,Enlarged radial head,HP:0003997,Hypoplastic radial head,0.8768,t
